Hearing the Light
Optogenetics Provides Bright New Prospects for Hearing Restoration
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
For full access to this article login to GEN Select now.
Timing Is Everything in Protein Formulation
Choosing When and How to Proceed Depends on Available Resources and Competition
- Formulation can make or break a development-stage protein drug, and add years of IP protection and value for post-patent molecules. Yet significant disagreement exists on the best time to undertake the formulation investment. Robert E. Zoubek, Ph.D., head of protein characterization and preformulation at Formycon, a business unit ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.